NFE2L2 and deep vein thrombosis: Other studies have found that epigallocatechin-3-gallate promotes deep vein thrombosis resolution by regulating EPCs iron death via the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway (as shown in Table 3) (Li et al., 2025).